PREPARATION AND ASSESSMENT OF NAIL LACQUER INCORPORATING CICLOPIROX OLAMINE-LOADED NIOSOMES
DOI:
https://doi.org/10.22159/ajpcr.2025v18i4.53933Keywords:
Transungual, Niosomes, Onychomycosis, Nail lacquer, Antifungal activityAbstract
Objective: The emergence of transungual drug delivery systems represents a significant advancement in treating nail-related conditions, particularly fungal infections like onychomycosis. The current study aims to formulate ciclopirox olamine (CPO)-loaded niosomal nail lacquer for the treatment of onychomycosis.
Methods: CPO niosomes were synthesized using the thin-film hydration method, incorporating different proportions of cholesterol, Span 60, and Tween 40. Niosomes were assessed for their drug content, encapsulation efficiency, particle size, and zeta potential.
Results: Among various formulations of niosomes, the formulation F5 showed adequate drug loading of 94.51%, polydispersity index of 0.171, and zeta potential of −5.10 mV. Following that, the optimized formulation (F5) of the niosomal suspension was used to develop nail lacquer formulation. The optimized nail lacquer formulation (F5) showed the maximum in vitro drug release, achieving a rate of 92.22%. The ex vivo transungual study of the optimized formulation was conducted using Franz diffusion cell apparatus, resulting in a drug release rate of approximately 90.67%. The zone of inhibition obtained for niosomal nail lacquer formulation was found more than the pure drug solution.
Conclusion: The oral administration of antifungal agents, such as allylamines and azoles, is associated with numerous adverse effects resulting from the requirement for high dosages. These issues can be addressed by formulating such medications as nail lacquer, using significantly lower dosages for treatment, which consequently leads to reduced side effects
Downloads
References
Abd-Elsalam WH, Abouelatta SM. Contemporary techniques and potential transungual drug delivery nanosystems for the treatment of onychomycosis. AAPS PharmSciTech. 2023;24(6):150. doi: 10.1208/ s12249-023-02603-x
Yousefian F, Smythe C, Han H, Elewski BE, Nestor M. Treatment options for onychomycosis: Efficacy, side effects, adherence, financial considerations, and ethics. J Clin Aesthet Dermatol. 2024;17(3):24-33. PMID 38495549
Mahajan K, Grover C, Relhan V, Tahiliani S, Singal A, Shenoy MM, et al. Nail society of India recommendations for treatment of onychomycosis in special population groups. Indian Dermatol Online J. 2024;15(2):196-204. doi: 10.4103/idoj.idoj_578_23, PMID 38550843
Gupta AK, Wang T, Polla Ravi S, Mann A, Bamimore MA. Global prevalence of onychomycosis in general and special populations: An updated perspective. Mycoses. 2024;67(4):e13725. doi: 10.1111/ myc.13725, PMID 38606891
Chakraborty S, Sanshita, Singh I. Therapeutic treatment strategies for the management of onychomycosis: A patent perspective. Expert Opin Ther Pat. 2023;33(9):613-30. doi: 10.1080/13543776.2023.2268278, PMID 378008546. Gupta AK, Wang T, Cooper EA, Summerbell RC, Piguet V, Tosti A, et al. A comprehensive review of nondermatophyte mould onychomycosis: Epidemiology, diagnosis and management. J Eur Acad Dermatol Venereol. 2024;38(3):480-95. doi: 10.1111/jdv.19644, PMID 38010049
Sharma K, Yadav V, Reang J, Sharma K, Tonk RK, Jain P, et al. Overview of the current advancements and trends in the transungual drug delivery system. Lett Drug Des Discov. 2024;21(8):1316-24. doi: 10.2174/1570180820666230306140637
Barani M, Paknia F, Roostaee M, Kavyani B, Kalantar- Neyestanaki D, Ajalli N, et al. Niosome as an effective nanoscale solution for the treatment of microbial infections. Biomed Res Int. 2023;2023(1):9933283. doi: 10.1155/2023/9933283, PMID 37621700
Triveni, Nagaich U, Mishra DK, Jain N. Full factorial design-based development and characterization of ciclopirox olamine loaded transferosomes: An efficient approach for the management of athlete’s foot. J Drug Deliv Sci Technol. 2024;99:105939. doi: 10.1016/j.jddst.2024.105939
Kishishita J, De Almeida Perez Pimenta C, Cerqueira Macedo DP, Delgado-Charro MB, Bastos Leal L. New formulation-microporation combination approaches to delivering ciclopirox across human nails. Pharmaceutics. 2024;16(1):72.
Marri RR, Nithisha M, Apurva M, Prasanthi R, Mamatha T. Formulation and In vitro evaluation of niosomal gel for the topical administration of losartan potassium. J Drug Deliv Ther. 2024;14(1):41-8.
Mughal TA, Ali S, Mumtaz S, Summer M, Saleem MZ, Hassan A, et al. Evaluating the biological (antidiabetic) potential of TEM, FTIR, XRD, and UV-spectra observed Berberis lyceum conjugated silver nanoparticles. Microsc Res Tech. 2024;87(6):1286-305. doi: 10.1002/ jemt.24509, PMID 38351883
Abonashey SG, Hassan HA, Shalaby MA, Fouad AG, Mobarez E, El- Banna HA. Formulation, pharmacokinetics, and antibacterial activity of florfenicol-loaded niosome. Drug Deliv Transl Res. 2024;14(4):1077- 92. doi: 10.1007/s13346-023-01459-9, PMID 37957473
Asrori MR, Santoso A, Sumari S. Proofing the presence of metal oxide impregnated into zeolite A without calcination: XRD and FTIR studies. Case Stud Environ Eng. 2024;9:100676. doi: 10.1016/j.cscee.2024.100676
Riccardi D, Baldino L, Reverchon E. Liposomes, transfersomes and niosomes: Production methods and their applications in the vaccinal field. J Transl Med. 2024;22(1):339. doi: 10.1186/s12967-024-05160- 4, PMID 38594760
Mawazi SM, Ann TJ, Widodo RT. Exploring the evolution of niosomes: From past techniques to future advances in preparation methods-a comprehensive review methods. BioNanoScience. 2024;14(2):1854- 75. doi: 10.1007/s12668-024-01395-z
Gupta AK, Polla Ravi S, Choi SY, Konda A, Cooper EA. Strategies for the enhancement of nail plate permeation of drugs to treat onychomycosis. J Eur Acad Dermatol Venereol. 2023;37(2):243-55. doi: 10.1111/jdv.18638, PMID 36196052
Chauhan P, Pahwa R, Kumari P, Kumar T, Ahuja M. Development and evaluation of luliconazole nail lacquer containing potential permeation enhancers for an enhanced transungual drug delivery. Drug Deliv Lett. 2023;13(1):35-47. doi: 10.2174/2210303113666221117085703
Faddah H, Nsairat H, Shalan NM, El-Tanani M, Alqudah DA, Alshaer W. Preparation, optimization and In vitro evaluation of doxorubicin-loaded into hyaluronic acid coated niosomes against breast cancer. Chem Biodivers. 2024;21(2):e202301470. doi: 10.1002/cbdv.202301470, PMID 38161147
Rezaei H, Iranbakhsh A, Sepahi AA, Mirzaie A, Larijani K. Formulation, preparation of niosome loaded zinc oxide nanoparticles and biological activities. Sci Rep. 2024;14(1):16692. doi: 10.1038/ s41598-024-67509-5, PMID 39030347
Aneesha V, Gopi S, Rasel Jose J, Karan S, Snehadevi M, Jeevanandham S, et al. Formulation and evaluation of herbal antifungal nail lacquer for the treatment of onychomycosis. World J Pharm Res. 2015;13(1):1779-90.
Mineto AR, De Matos SP, Bordignon IM, Ribeiro R, Apel MA, Da Veiga-Junior VF, et al. Development by design of experiment and validation of a HPLC-UV method for simultaneous quantification of 1-nitro-2-phenylethane and methyleugenol: Application to nail permeation/retention studies. J Pharm Biomed Anal. 2024;239:115889. doi: 10.1016/j.jpba.2023.115889, PMID 38056286
Kumar Behera J, Kumar S, Sharma R, Jain A, Kumar Garg N, Khopade A, et al. Novel discoveries and clinical advancements for treating onychomycosis: A mechanistic insight. Adv Drug Deliv Rev. 2024;205:115174. doi: 10.1016/j.addr.2023.115174, PMID 38161056
Tanwar H, Sharma M, Ahuja M. Preparation and evaluation of berberine chloride loaded poloxamer gel for transungual delivery. Ann Biol. 2024;40(1):73-80.
Chauhan A, Nainwal N, Butola M, Jakhmola V. Exhaustive review on nail lacquer in the treatment of nail diseases. Philipp J Sci. 2023 Oct 1;152(5):1895-909.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Mansi Butola
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
